Devi Desai, MSW, LCSW, ACM-SW, was recently elected as a Board Member-at-Large to serve a two-year term with the American Case Management Association (ACMA) National Board of Directors. Her term started on April 20 when the group — whose members include nurses, social workers, physicians, administrators, and other professionals — held their annual national conference in Washington, DC.
Desai, a social worker by profession, has served in oncology at Duke for nearly 20 years, with the last seven years as Case Manager Team Lead for oncology, float and weekend case managers. She previously served on the NC ACMA board from 2007 to 2012, ACMA Poster Review Committee (2008-2010), ACMA National Board for Case Management Committee (2010-2012) and ACMA Public Policy Committee from 2012-2015.
“We are very proud of Devi!” said Michelle Hocutt, MSN, RN, OCN, the interim Clinical Operations Director for the Adult Bone Marrow Transplant (ABMT) Clinic and Adult Oncology Inpatients Units at Duke University Medical Center. “Devi is a collaborative, innovative and results–driven professional. She is highly respected by the medical and interdisciplinary team for her expertise, creative problem solving skills, and willingness to share the latest developments in case management to best serve our patients. Duke is fortunate to have her on the oncology team."
Desai’s board responsibilities will include attending four live meetings and five to six conference call board meetings annually, assignments as board liaison to committees, working with committees to achieve their annual goals/outcomes and other leadership responsibilities.
"This is an exciting and challenging time across the country as the delivery of healthcare is changing in important ways," said Desai. "I can leverage my many years of experience in the field to contribute to ACMA’s goals of supporting the professional development of its members, mentoring and providing knowledge resources. We all benefit when we pool our knowledge and expertise! Through our work at Duke, my colleagues and I observe important regulatory challenges as well as new opportunities for regulatory reforms. Although reforming regulations is a long and difficult process, being on the board, I can give voice to our observations.”